Table 1 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms

Table 1 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms

<p>Patient demographics.</p>

Đã lưu trong:

Chi tiết về thư mục
Tác giả chính:	James R. Larkin (14936324) (author)
Tác giả khác:	Susan Anthony (15039111) (author), Vanessa A. Johanssen (15039114) (author), Tianrong Yeo (15039117) (author), Megan Sealey (12045959) (author), Abi G. Yates (14029965) (author), Claire Friedemann Smith (15039120) (author), Timothy D.W. Claridge (15039123) (author), Brian D. Nicholson (2889917) (author), Julie-Ann Moreland (15039126) (author), Fergus Gleeson (4055239) (author), Nicola R. Sibson (14936336) (author), Daniel C. Anthony (15039129) (author), Fay Probert (849357) (author)
Được phát hành:	2025
Những chủ đề:	Cancer Molecular and Cellular Biology Cancer Detection and Diagnosis Methods and Technology Biomarkers Diagnostic biomarkers Early detection biomarkers Liquid Biopsy Metabolism Metabolomics Tumor Staging
Các nhãn:	Thêm thẻ Không có thẻ, Là người đầu tiên thẻ bản ghi này!

Những quyển sách tương tự

Figure 1 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
Bằng: James R. Larkin (14936324)
Được phát hành: (2025)

Figure 2 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
Bằng: James R. Larkin (14936324)
Được phát hành: (2025)

Figure 3 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
Bằng: James R. Larkin (14936324)
Được phát hành: (2025)

Figure 4 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
Bằng: James R. Larkin (14936324)
Được phát hành: (2025)

Figure 5 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
Bằng: James R. Larkin (14936324)
Được phát hành: (2025)

Supplementary Table S4 from Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)
Bằng: Chaoyang Zhang (15051876)
Được phát hành: (2025)

Supplementary Table S6 from Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)
Bằng: Chaoyang Zhang (15051876)
Được phát hành: (2025)

Supplementary Tables S1-S15 from Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells
Bằng: Iris van 't Erve (15054503)
Được phát hành: (2025)

Supplementary Figure S1 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
Bằng: Kala Visvanathan (14952973)
Được phát hành: (2025)

Supplementary Figure S2 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
Bằng: Kala Visvanathan (14952973)
Được phát hành: (2025)

Supplementary Figure S3 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
Bằng: Kala Visvanathan (14952973)
Được phát hành: (2025)

Supplementary Figure S4 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
Bằng: Kala Visvanathan (14952973)
Được phát hành: (2025)

Supplementary Figure S5 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
Bằng: Kala Visvanathan (14952973)
Được phát hành: (2025)

Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
Bằng: Emil Christensen (15054394)
Được phát hành: (2025)

Supplementary Table S2 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
Bằng: Emil Christensen (15054394)
Được phát hành: (2025)

Supplementary Data 2 from Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study
Bằng: Ismael Fernández-Miranda (15051932)
Được phát hành: (2025)

Supplementary Table S1 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Bằng: Sofie H. Tolmeijer (15313251)
Được phát hành: (2025)

Supplementary Table S2 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Bằng: Sofie H. Tolmeijer (15313251)
Được phát hành: (2025)

Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Bằng: Sofie H. Tolmeijer (15313251)
Được phát hành: (2025)

TS1-9 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
Bằng: Lavanya Sivapalan (15314248)
Được phát hành: (2025)

Integrating urinary metabolomics and clinical datasets for multi-cancer detection
Bằng: Dongyong Lee (18786694)
Được phát hành: (2025)

Supplementary Data S1 from Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor–Positive (HR+)/HER2-Negative Metastatic Breast Cancer
Bằng: Andrew A. Davis (15030032)
Được phát hành: (2025)

Supplemental Table 1 from Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
Bằng: Morten Lapin (15056728)
Được phát hành: (2025)

Supplemental Table 2 from Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
Bằng: Morten Lapin (15056728)
Được phát hành: (2025)

Supplemental Table 3 from Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
Bằng: Morten Lapin (15056728)
Được phát hành: (2025)

Supplementary Data 1 from Monitoring Sarcoma Response to Immune Checkpoint Inhibition and Local Cryotherapy with Circulating Tumor DNA Analysis
Bằng: Nam Q. Bui (14958210)
Được phát hành: (2025)

Data Sheet 3_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
Bằng: Hailong Pang (12841991)
Được phát hành: (2025)

Data Sheet 2_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
Bằng: Hailong Pang (12841991)
Được phát hành: (2025)

Data Sheet 1_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
Bằng: Hailong Pang (12841991)
Được phát hành: (2025)

ROC curve analysis of a set of biomarkers obtained via untargeted metabolomics in serum samples from children infected with DENV compared to Control.
Bằng: Ricardo E. Correa Fierro (22676430)
Được phát hành: (2025)

Workflow of untargeted metabolomics in serum samples from children infected with DENV.
Bằng: Ricardo E. Correa Fierro (22676430)
Được phát hành: (2025)

Table 1_Cross-species validation of a 6-miRNA blood signature for Parkinson’s disease: from MPTP mice to human PBMC and serum exosomes.docx
Bằng: Nagyum Jung (22686458)
Được phát hành: (2025)

Supplementary Table S3 from Circulating Exosomal PD-L1 at Initial Diagnosis Predicts Outcome and Survival of Patients with Osteosarcoma
Bằng: Jun Wang (15051911)
Được phát hành: (2025)

PLS-DA regression model from untargeted metabolomics of serum samples from children infected with dengue and controls.
Bằng: Ricardo E. Correa Fierro (22676430)
Được phát hành: (2025)

Supplementary Figure S7 from <i>NPY</i> Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer
Bằng: Katleen Janssens (15053356)
Được phát hành: (2025)

CD38CD39 Population DEGs DS1 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
Bằng: Ankita Mitra (17141783)
Được phát hành: (2025)

Figure S1 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
Bằng: Jamunarani Veeraraghavan (16461809)
Được phát hành: (2025)

Figure S2 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
Bằng: Jamunarani Veeraraghavan (16461809)
Được phát hành: (2025)

Figure S3 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
Bằng: Jamunarani Veeraraghavan (16461809)
Được phát hành: (2025)

Figure S4 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
Bằng: Jamunarani Veeraraghavan (16461809)
Được phát hành: (2025)

Cannot write session to /tmp/vufind_sessions/sess_jho95e5mbfv3v5sor66nrrjiht